A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics.

作者: Xian Xu , Chandran R. Sabanayagam , Daniel A. Harrington , Mary C. Farach-Carson , Xinqiao Jia

DOI: 10.1016/J.BIOMATERIALS.2013.12.080

关键词:

摘要: Three-dimensional (3D) tissue-engineered tumor models have the potential to bridge gap between monolayer cultures and patient-derived xenografts for testing of nanoparticle (NP)-based cancer therapeutics. In this study, a hydrogel-derived prostate (PCa) model was developed in vitro evaluation doxorubicin (Dox)-loaded polymer NPs (Dox-NPs). The hydrogels were synthesized using chemically modified hyaluronic acid (HA) carrying acrylate groups (HA-AC) or reactive thiols (HA-SH). crosslinked hydrogel networks exhibited an estimated pore size 70-100 nm, similar spacing extracellular matrices (ECM) surrounding tissues. LNCaP PCa cells entrapped HA formed distinct tumor-like multicellular aggregates with average diameter 50 μm after 7 days culture. Compared grown on two-dimensional (2D) tissue culture plates, from engineered tumoroids expressed significantly higher levels multidrug resistance (MDR) proteins, including protein 1 (MRP1) lung resistance-related (LRP), both at mRNA levels. Separately, Dox-NPs 54 ± nm prepared amphiphilic block copolymers based poly(ethylene glycol) (PEG) poly(e-caprolactone) (PCL) bearing pendant cyclic ketals. able diffuse through matrices, penetrate into tumoroid be internalized by caveolae-mediated endocytosis macropinocytosis pathways. 2D cultures, cultured as more resistant Dox treatments. Moreover, NP-based formulation could bypass drug efflux function MRP1, thereby partially reversing free 3D cultures. Overall, has provide predictable results efficacy

参考文章(63)
Ji Wang, Zhi-xiang Zhuang, Shun-feng Luo, Hong Zhu, Hui Wang, Hong Zhang, Wang-yang Pu, Xin Li, Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α. Chinese Medical Journal. ,vol. 125, pp. 1095- ,(2012)
Vinata B. Lokeshwar, Wolfgang H. Cerwinka, Tadahiro Isoyama, Bal L. Lokeshwar, HYAL1 Hyaluronidase in Prostate Cancer: A Tumor Promoter and Suppressor Cancer Research. ,vol. 65, pp. 7782- 7789 ,(2005) , 10.1158/0008-5472.CAN-05-1022
Xin Wang, Xu Zhen, Jing Wang, Jialiang Zhang, Wei Wu, Xiqun Jiang, Doxorubicin delivery to 3D multicellular spheroids and tumors based on boronic acid-rich chitosan nanoparticles. Biomaterials. ,vol. 34, pp. 4667- 4679 ,(2013) , 10.1016/J.BIOMATERIALS.2013.03.008
Rakesh K. Jain, Triantafyllos Stylianopoulos, Delivering nanomedicine to solid tumors Nature Reviews Clinical Oncology. ,vol. 7, pp. 653- 664 ,(2010) , 10.1038/NRCLINONC.2010.139
Claudia Fischbach, Ruth Chen, Takuya Matsumoto, Tobias Schmelzle, Joan S Brugge, Peter J Polverini, David J Mooney, Engineering tumors with 3D scaffolds. Nature Methods. ,vol. 4, pp. 855- 860 ,(2007) , 10.1038/NMETH1085
Elizabeth Garcia-Garcia, Karine Andrieux, Sophie Gil, Hyun Ryoung Kim, Trung Le Doan, Didier Desmaële, Jean d’Angelo, Frédéric Taran, Dominique Georgin, Patrick Couvreur, A methodology to study intracellular distribution of nanoparticles in brain endothelial cells. International Journal of Pharmaceutics. ,vol. 298, pp. 310- 314 ,(2005) , 10.1016/J.IJPHARM.2005.03.030
James D Byrne, Tania Betancourt, Lisa Brannon-Peppas, None, Active targeting schemes for nanoparticle systems in cancer therapeutics. Advanced Drug Delivery Reviews. ,vol. 60, pp. 1615- 1626 ,(2008) , 10.1016/J.ADDR.2008.08.005
Jinling Wang, Jin Sun, Qin Chen, Ying Gao, Lin Li, Hui Li, Donglei Leng, Yongjun Wang, Yinghua Sun, Yongkui Jing, Siling Wang, Zhonggui He, Star-shape copolymer of lysine-linked di-tocopherol polyethylene glycol 2000 succinate for doxorubicin delivery with reversal of multidrug resistance. Biomaterials. ,vol. 33, pp. 6877- 6888 ,(2012) , 10.1016/J.BIOMATERIALS.2012.06.019
Xiao Zheng Shu, Yanchun Liu, Fabio S Palumbo, Yi Luo, Glenn D Prestwich, In situ crosslinkable hyaluronan hydrogels for tissue engineering Biomaterials. ,vol. 25, pp. 1339- 1348 ,(2004) , 10.1016/J.BIOMATERIALS.2003.08.014